BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20393986)

  • 1. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma (Br J Surg 2009; 96: 1300-1307).
    Clark E; Krishnan A; Dunn LJ; Robertson AG; Griffin SM
    Br J Surg; 2010 May; 97(5):792-3; author reply 793. PubMed ID: 20393986
    [No Abstract]   [Full Text] [Related]  

  • 2. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma.
    Morgan MA; Lewis WG; Casbard A; Roberts SA; Adams R; Clark GW; Havard TJ; Crosby TD
    Br J Surg; 2009 Nov; 96(11):1300-7. PubMed ID: 19847875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
    Bedenne L
    Ann Chir; 1997; 51(6):605-10. PubMed ID: 9406457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer (Br J Surg 2003; 90: 1373-1378).
    Ziprin P; Clarke J
    Br J Surg; 2004 Feb; 91(2):253-4. PubMed ID: 14760683
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multimodal therapy of esophageal cancer].
    Hartwig W; Strobel O; Lordick F; Büchler MW; Werner J
    Z Gastroenterol; 2008 Oct; 46(10):1207-13. PubMed ID: 18937192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal therapy for squamous carcinoma of the oesophagus.
    Lehnert T
    Br J Surg; 1999 Jun; 86(6):727-39. PubMed ID: 10383570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant chemoradiotherapy in esophageal cancer].
    Cordiano C; Laterza E; Urso SU; Castaldini G
    Chir Ital; 1994; 46(3):11-5. PubMed ID: 8001187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the esophagus: treat with how many modalities?
    Cheng S; Iannettoni M; Koshy M; Suntharalingam M; Urba S
    Semin Oncol; 2009 Dec; 36(6):493-7. PubMed ID: 19995639
    [No Abstract]   [Full Text] [Related]  

  • 10. Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
    Irwin JF; Waterfield W; Poussin-Rosillo H; Sardi A
    Md Med J; 1997 Oct; 46(9):471-76. PubMed ID: 9327648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
    McDonnell CO; Harmey JH; Bouchier-Hayes DJ; Walsh TN
    Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
    Elsaleh H; Farrell JJ; Crane CH
    J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy and multimodality therapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Kitajima M; Iizuka T
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):869-76. PubMed ID: 7540823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodality therapy for cancers of the esophagus and gastric cardia.
    Naughton P; Walsh TN
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):141-50. PubMed ID: 14748664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The neoadjuvant treatment of gastrointestinal tumors: time for rethinking?].
    Ebert MP; Schmid RM
    Dtsch Med Wochenschr; 2009 Sep; 134(37):1835-7. PubMed ID: 19728255
    [No Abstract]   [Full Text] [Related]  

  • 20. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
    Epari K; Cade R
    ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.